This is the protocol for a review and there is no abstract. The objectives are as follows:
The main questions we wish to address are as follows.
Are beta blockers effective in preventing stroke recurrence?
Can beta blockers reduce major vascular events, vascular death and death from all causes in patients with prior stroke and TIA?
Do beta blockers increase the risk of developing diabetes?